| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | -0.012 | 0.7 |
| mRNA | KIN001-244 | GDSC1000 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | HG-5-88-01 | GDSC1000 | pan-cancer | AAC | 0.015 | 0.8 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | KU-0063794 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | -0.016 | 0.8 |